Phase 3 Neutrophil Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGranulomatosis With Polyangiitis

Assistance Publique - Hôpitaux de Paris42 enrolled1 locationNCT04871191

Recruiting

Phase 3

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisEnd Stage Renal Disease

Centre Hospitalier Departemental Vendee136 enrolled58 locationsNCT03323476